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dichloromethane (DCM) (10 mL), and DMF (10 mL) between coupling and deprotection steps. N--terminal acetylated peptides were generated by treating the terminally deprotected resin-bound peptide with a cocktail containing acetic anhydride, DIPEA, and DMF (2 mL, in a 85:315:1600 volumetric ratio) and stirring at room temperature for 45 min. 1 The resin was then washed thoroughly with DMF (10 mL), DCM (10 mL), and methanol (MeOH) (5 mL) and dried overnight under nitrogen. Once the synthesis was complete, peptides were cleaved from the resin in a CEM MARS reaction vessel using 2--4 mL of a cocktail containing water (2.5%), triisopropylsilane (2.5%), and TFA (95%). Cleaved peptides were precipitated with diethyl ether (40 mL, chilled to --80 o C), lyophilized to dryness, and reconstituted in 7 mL water containing a trace amount of acetonitrile prior to purification by HPLC.
Hydrocarbon--stapled peptides.
Peptides containing hydrocarbon staples were synthesized using the procedures described for native peptides except that olefinic amino acids (3 eq) were coupled using NMP (3 mL), DIPEA (6 eq) and Pyclock (3 eq) for 2 h at RT 1 and cyclized on--resin, immediately prior to acetylation, using Grubbs Catalyst I (20 eq) in DCE (4 mL) for 2 h under N 2 . 1 This cyclization step was repeated twice. 1 S4 Figure S1 . Structures of native and hydrocarbon--stapled peptides studied in this work. C. S5
Automated synthesis. This procedure was used for molecules used in Figure 4 .
N--terminally biotinylated peptides and N--terminally SDex--conjugated peptides were synthesized on a 100 µmol scale using standard solid--phase Fmoc chemistry with H--Pal
ChemMatrix® resin on a Biotage® Initiator+ Alstra from Biotage (Charlotte, NC). For standard amino acid couplings, DMF (4.5 mL), HBTU (4 eq), DIPEA (8 eq), and Fmoc--protected amino acid (4 eq) were subjected to microwave--assisted standard amino acid couplings (75 o C for 5 minutes). All arginine residues were coupled twice. To couple olefinic residues, DMF (4.5 mL), Pyclock (6 eq), Fmoc--protected olefinic amino acids ((Fmoc--R 5 --OH, Fmoc--S 5 --OH, or Fmoc--R 8 --OH) (3 eq) were combined and allowed to stir at RT for 2 h. 1 . Fmoc groups were removed by treating the resin twice with 20% piperidine in DMF (4.5 mL) with microwave assistance (70°C for 3 min). The resin was washed thoroughly with DMF (4 x 4.5 mL) between each coupling and deprotection step. After synthesis, the resin was transferred to a custom glass reactions vessel containing a stir bar coated with SigmaCote. Peptides containing hydrocarbon staples were cyclized on--resin, as described above, prior to N--terminal biotinyation or SDex--conjugation. 1 N-terminal biotinylated peptides were generated by treating the terminally deprotected resin-bound peptide with EZ--link® NHS--LC--Biotin (2 eq) and DIPEA (2 eq) in DMF (3 mL) for 4 h at RT.
N--terminal SDex--conjugated peptides were generated by treating the terminally deprotected resin--bound peptide with SDex (2.5 eq), HATU (2.5 eq), HOAt (2.5 eq), 2,6--lutidine (7 eq) and DIPEA (10 eq) in DMF (2.5 mL) for 4 h at RT, protected from light. 2 Once the peptide synthesis was complete, the resin was then washed, dried, and cleaved, as described above in section S3 . CD spectra of peptides described in Figure   S1 , S2, and Table S1 . Plots show background-subtracted averages of six scans. S9 
Western Blot Analysis
The levels of EGFR phosphorylation were monitored using antibodies specific for the following containing 2% SDS in water and washing buffer (1:5 ratio), was rotated with the beads for 30 min at room temperature. The washed beads were then incubated with 100 µL elution buffer (2% SDS in water) at 95°C for 5 minutes to elute sequestered proteins, which were then resolved by SDS--PAGE using a 10% polyacrylamide gel (Mini--PROTEAN® TGX TM Precast Mini Gels, BioRad), followed by transfer to PVDF membranes (iBlot apparatus, Life Technologies).
Lysate Preparation and Treatment -EGFR Pulldowns

Western Blot Analysis
The levels EGFR were monitored using an anti--EGFR antibody (Cell Signaling, Product #4267).
Specifically, iBlot transfer membranes (iBlot® Transfer Stack, PVDF, regular size) were blocked with 5% milk in TBS--T (50 mM Tris, 150 mM NaCl, 0.1 % Tween, pH 7.4) for 1--2 h, followed by incubation with an anti--EGFR primary antibody (Product #4267, 1:1000 dilution) for 16--18 h at 4 o C (Cell Signaling). The membranes were washed three times with TBS--T (1 x 5 min, 2 x 10 min) and exposed to a secondary HRP--conjugated antibody (Product #7074, 1:5000 dilution) for 1--2 h (Cell Signaling). The membranes were washed with TBS--T (1 x 5 min, 2 x 10 min), then developed using a Immun--Star™ WesternC™ Chemiluminescence Kit (BioRad).
Chemiluminescent detection was performed using a ChemiDoc XRS+ (BioRad). Total band intensities were quantified with the gel analysis function of ImageJ, version 1.46r, and normalized to the untreated sample band intensities (NIH, USA). 3
D. Bipartite Tetracysteine Display
Materials
The plasmid encoding CCH--1 EGFR was prepared as described previously. 4 EGF was purchased from Fisher Scientific (Suwance, GA). ReAsH and α--mouse Alexa Fluor® 488 antibodies were S18 
Cell Treatment for Surface ReAsH Labeling Studies
CHO cells were transfected with CCH--1 EGFR, then treated as described previously, 4 except that an aliquot of peptide dissolved in ATP inhibition media (10 mM NaN 3 , 2 mM NaF, 5 mM 2-deoxy--D--glucose, and pen--strep in F12K Medium) was added to the cells for 1 h at 37 o C, prior to growth factor stimulation.
Total Internal Reflectance Fluorescence Microscopy (TIR--FM)
TIRF--M images were obtained using a Leica AM TIRF MC (Leica Microsystems, Wetzlar, Germany) as previously reported. 4 S19 Figure S8 . 
Concentration
